Key statistics dashboard for Enveric Biosciences, Inc. (ENVB). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application.
Stock Data
| Price | $1.49 |
| Market Cap | $1M |
| Enterprise Value | -$7.4M |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.09 |
| Price / Book | 0.74 |
| P/S | 0.00 |
| EV/EBITDA | 0.86 |
| EV/Sales | 0.00 |
| EV/FCF | 0.87 |
| P/FCF | -0.10 |
| Earnings Yield | -146.93% |
| FCF Yield | -962.42% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 0.00% |
| EBIT Margin | 0.00% |
| EBITDA Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | -168.05% |
| Return on Assets | -97.60% |
| Return on Invested Capital | -107.99% |
| Return on Capital Employed | -107.99% |
Financial Health
| Current Ratio | 10.21 |
| Quick Ratio | 10.21 |
| Cash Ratio | 9.63 |
| Debt / Equity | 0.00 |
| Debt / Assets | 0.00% |
| Net Debt / EBITDA | 0.97 |
| Interest Coverage | -10329.56 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -35.49 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | 2.03 |
| Cash per share | 2.08 |
| FCF per share | -2.15 |
| Tangible Book Value per share | 2.03 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 3 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 4 |
| Avg rating (1-5) | 0.75 |
Related companies: AZTR · HEPA · INDP · JSPR · ONCO · SCNI · SLRX
Explore sector: Healthcare · Biotechnology
More sections of ENVB: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks